Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Atherosclerosis IV: Nursing Management01:23

Atherosclerosis IV: Nursing Management

Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Inhalation of nanoparticles during pregnancy enhances placental glucose transport in rats.

bioRxiv : the preprint server for biology·2026
Same author

Micro and nanoplastic inhalation during gestation disrupts placentation in the Sprague-Dawley rat.

Research square·2026
Same author

Polystyrene Nanoplastics Disrupt Mouse Placenta Development in a Sex-Dependent Manner.

bioRxiv : the preprint server for biology·2026
Same author

Methodology, characterization, and multiple-path particle dosimetry modeling of laboratory inhalation exposure for micro-nanoplastic particles in rodents.

Microplastics and nanoplastics·2026
Same author

An algorithm for generating biophysically realistic three-dimensional arteriolar networks applied to rat skeletal muscle.

Physiological reports·2025
Same author

Micro and nanoplastic inhalation during pregnancy elicits uterine endothelial dysfunction in Sprague Dawley rats by impeding nitric oxide signaling.

American journal of physiology. Heart and circulatory physiology·2025
Same journal

Administration of human macrophage colony-stimulating factor-mFc fusion protein increases macrophage phagocytic capacity and stimulates liver regeneration in mice.

Journal of inflammation (London, England)·2026
Same journal

Editorial Expression of Concern: The occurrence and development of radiation-induced lung injury after interstitial brachytherapy and stereotactic radiotherapy in SD rats.

Journal of inflammation (London, England)·2026
Same journal

FOXD2-AS1/miR-185-5p/CDC42 axis in chronic obstructive pulmonary disease: clinical significance and mechanistic insights.

Journal of inflammation (London, England)·2026
Same journal

A spotlight on the inflammatory role of uremic toxins in the dysbiosis-CKD axis: a review.

Journal of inflammation (London, England)·2026
Same journal

Myeloperoxidase regulates hypoxia-induced inflammation and oxidative stress in liver-spleen axis.

Journal of inflammation (London, England)·2026
Same journal

Resolvin D1 attenuates senescence-associated secretory phenotype independently of TGF-β-driven cardiac fibroblasts differentiation to myofibroblast.

Journal of inflammation (London, England)·2026
See all related articles

Related Experiment Video

Updated: Jun 6, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

Hypercholesterolemia and microvascular dysfunction: interventional strategies.

Phoebe A Stapleton1, Adam G Goodwill, Milinda E James

  • 1Center for Cardiovascular and Respiratory Sciences, West Virginia University School of Medicine, 1 Medical Center Drive, Morgantown, WV 26506, USA. jfrisbee@hsc.wvu.edu.

Journal of Inflammation (London, England)
|November 20, 2010
PubMed
Summary
This summary is machine-generated.

High cholesterol (hypercholesterolemia) increases cardiovascular risk. This review examines how cholesterol-lowering drugs and exercise impact inflammation, oxidative stress, and microvascular function in hypercholesterolemia.

More Related Videos

LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring
08:45

LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring

Published on: November 17, 2018

Related Experiment Videos

Last Updated: Jun 6, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring
08:45

LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring

Published on: November 17, 2018

Area of Science:

  • Cardiovascular Science
  • Endocrinology
  • Exercise Physiology

Background:

  • Hypercholesterolemia, high cholesterol levels, is a major risk factor for cardiovascular diseases like peripheral vascular disease (PVD) and coronary artery disease (CAD).
  • Elevated cholesterol is linked to endothelial dysfunction, reduced nitric oxide, increased oxidative stress, and inflammation, impairing vascular reactivity.

Purpose of the Study:

  • To review the mechanistic effects of pharmaceutical interventions and chronic exercise on hypercholesterolemia.
  • To analyze impacts on chronic inflammation, oxidative stress, and microvascular structure and function.

Main Methods:

  • Literature review of pharmaceutical therapies for hypercholesterolemia.
  • Analysis of studies on the effects of chronic physical activity on cardiovascular risk factors and vascular function.

Main Results:

  • Pharmaceuticals decrease cholesterol by inhibiting synthesis or absorption, offering direct vascular benefits.
  • Physical activity reduces PVD/CAD risk factors and improves high-density lipoprotein, cardiac, and vascular function.

Conclusions:

  • Both pharmaceutical treatments and exercise demonstrate pleiotropic effects beneficial for vascular health in hypercholesterolemia.
  • Understanding these mechanisms is crucial for managing hypercholesterolemia and preventing cardiovascular events.